Neonicotinoids May Harm Wild Bees

Exposure to neonicotinoid pesticides is correlated with population declines of a large number of wild bee species, according to a field study conducted in the U.K.

Written byAshley P. Taylor
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

WIKIMEDIA, ROSENDAHLTreatment of oilseed rape, a major flowering crop grown in England, with neonicotinoid pesticides is correlated with population declines of wild bees, according to a study published today (August 16) in Nature Communications, in which researchers examined links between the area of chemical-treated crops and populations of 62 wild bee species across parts of the U.K. for 18 years.

In analyzing their data, researchers from the NERC Centre for Ecology and Hydrology and Fera Science Limited, separated the bee species into those that forage on oilseed rape and those that do not, finding that the oilseed-rape foragers were three times as negatively affected by agricultural neonicotinoid use as those that foraged on other plants. “From a correlative perspective, there’s an underlying mechanism that’s driving [the decline] and . . . it’s likely to be exposure to neonicotinoids applied to the oilseed rape crop,” said study coauthor Ben Woodcock.

“Taken as a whole, the paper provides the best evidence I’ve seen to indicate that neonicotinoids applied to oilseed rape have had a measurable impact on the distributions of wild bee species that feed on the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies